Boehringer Ingelheim strengthens antibody-drug conjugate portfolio with new NBE Therapeutics R&D center in Basel
CHF 27 million investment significantly bolsters Boehringer's ADC portfolio, driven by its…
Innate Pharma to Participate in the 2025 Stifel Virtual Targeted Oncology Forum
MARSEILLE, France--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA)…
NCCN 2025 Annual Conference Illustrates the Critical Impact of Cancer Research on Improving Lives
The National Comprehensive Cancer Network celebrated its 30th anniversary with a series…
Oxford BioTherapeutics Enters into a Strategic Collaboration with Roche to Discover Novel Targets for Antibody-Based Therapeutics for the Treatment of Cancer
March 19, 2025 04:00 ET | Source: Oxford BioTherapeutics Collaboration leverages OBT’s…
Press Release Biocartis NV: Biocartis Announces Multiple Abstracts Demonstrating the Impact of Idylla in Oncology Diagnostics to be Presented at USCAP 2025 Annual Meeting
PRESS RELEASE 18/03/2025, 07:00 CET Biocartis Announces Multiple Abstracts Demonstrating the Impact…
Sutro Biopharma Presents Data from Dose-Optimization Portion of REFRME-O1 Trial in Patients with Platinum Resistant Ovarian Cancer at SGO 2025
- The late-breaking oral presentation at SGO 2025 highlights consistent response rates…
MTF Biologics Appoints Donald Hackbarth and Sharon Gabrielson to Key Leadership Roles on Board of Directors
Industry Leaders Bring Extensive Expertise to Advance MTF Biologics’ Mission of Honoring…
BostonGene to Showcase Multi-Modal AI-Powered Platform at the 22nd Annual Meeting of the Japanese Society of Medical Oncology
Advancing Precision Oncology with AI-Driven Multiomics for Optimized Therapy Selection and Improved…
Leading Healthcare Institutions Adopt MSK-ACCESS for Liquid Biopsy Testing
SOPHiA GENETICS enables institutions across the globe to launch world-class oncology testing…
Predictive Oncology Closes Registered Direct Offering
February 19, 2025 17:20 ET | Source: Predictive Oncology Inc. PITTSBURGH, Feb.…